InvestorsHub Logo
Followers 104
Posts 16409
Boards Moderated 0
Alias Born 06/24/2014

Re: Tim696969 post# 111

Wednesday, 03/30/2022 7:20:58 AM

Wednesday, March 30, 2022 7:20:58 AM

Post# of 121
Adagio Therapeutics Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to Meet Primary Endpoints with Statistical Significance Across Pre- and Post-exposure Prophylaxis and Treatment for COVID-19 and Plans to Seek U.S. Emergency Use Authorizat